Maven, now valued at $1.35 billion, is answering a countrywide demand: More fertility benefits

Maven, a women’s health clinic and benefits platform, has had no shortage of macroeconomic plot twists: from investors questioning its market size to the still on-going pandemic to, most recently, the startling overturn of Roe v. Wade.
But CEO and founder Kate Ryder stays optimistic. “This is a massive industry that’s full of entrenched interests and misaligned incentives and then there’s the government and the regulators. But I think that the change is afoot,” she said in an interview with TechCrunch.
“There’s a lot of stuff to be done here, but I think employers are actually recognizin

リンク元